OM DENNE EPISODE
In this session recorded at CMO Summit 2022, the panel discusses:
What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes
Speakers:
Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics
What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes
Speakers:
Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af PharmaTalkRadio.
ANDRE EPISODE I DENNE PODCAST
As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed.
In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug deve…
For more information, go to theconferenceforum.org
For more information, visit theconferenceforum.org
For more information, visit theconferenceforum.org
For more information, visit theconferenceforum.org
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Pharma Talk Radio, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.
